Everything Investors Need to Know About Investigational New Drug SubmissionsThe Motley Fool • 10/03/20
4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?24/7 Wall Street • 09/30/20
The 3 Best Dividend Aristocrats Retirees Can Buy With Market Volatility This HighSeeking Alpha • 09/29/20
J&J: most Phase 1/2a participants in COVID-19 vaccine developed neutralizing antibodiesMarket Watch • 09/25/20
Is JNJ Stock A Buy As Pharma Giant Starts Final-Phase Coronavirus Vaccine Trials?Investors Business Daily • 09/25/20
Compass Pathways' Leads the Way as the First Psychedelics Company To IPO on the NasdaqPRNewsWire • 09/24/20
4 Coronavirus Vaccine Makers Now in Phase III as J&J Begins StudyZacks Investment Research • 09/24/20
Johnson & Johnson Advances Coronavirus Vaccine Candidate; EUA Likely In Early 2021Benzinga • 09/23/20
Johnson & Johnson Is Latest To Start Final-Phase Testing For Covid-19 VaccineInvestors Business Daily • 09/23/20